Your session is about to expire
← Back to Search
Pembrolizumab for Soft Tissue Sarcoma
Study Summary
This trial is studying pembrolizumab with radiation therapy to see if it can better treat patients with soft tissue sarcoma.
- Soft Tissue Sarcoma
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2024 Phase 2 trial • 57 Patients • NCT03004183Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is enrollment currently open for this trial?
"Affirmative. Clinicaltrials.gov displays that this clinical study is recruiting participants, having been initially posted on 28th March 2018 and last edited 18th October 2022. 26 patients are required at a single clinic location."
What is the aggregate patient population enrolled in this clinical experiment?
"Affirmative. According to the information in clinicaltrials.gov, this medical study is actively looking for participants from a single site and has set an enrolment goal of 26 people. This trial was first created on March 28th 2018 and its details were most recently updated on October 18th 2022."
Could you provide a synopsis of the past experiments conducted with Pembrolizumab?
"Presently, there are 961 trials in effect for Pembrolizumab with 122 of them being Phase 3. Although Houston, Texas hosts the most studies for this medication, across the globe 35731 sites are actively researching it."
Share this study with friends
Copy Link
Messenger